Suchergebnisse - "Barlow, William E"

PubPharm (15)

1

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Ambrosone, C. | Zirpoli, G. | Hutson, A. | +17

CommentIn: J Clin Oncol. 2020 Jun 20;38(18):2111. - PMID 32315274

2

Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Sharma, P. | Barlow, W. | Godwin, A. | +19

3

Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study

enthalten in: Clinical breast cancer | 2019

von Larsen, V. | Barlow, W. | Yang, J. | +19

4

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230

enthalten in: Journal of the National Cancer Institute | 2019

von Moore, H. | Unger, J. | Phillips, K. | +22

CommentIn: J Natl Cancer Inst. 2019 Feb 1;111(2):107-108. - PMID 30371813

5

SWOG S0221 : a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Budd, G. | Barlow, W. | Moore, H. | +17

6

Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer : SWOG S0430

enthalten in: The oncologist | 2012

von Schott, A. | Barlow, W. | Albain, K. | +8

7

Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer : SWOG 0012

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2011

von Ellis, G. | Barlow, W. | Gralow, J. | +6

8

Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2010

von Yao, S. | Barlow, W. | Albain, K. | +15

9

Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer

enthalten in: Breast cancer research and treatment | 2010

von Yao, S. | Barlow, W. | Albain, K. | +15

10

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy : a retrospective analysis of a randomised trial

enthalten in: The Lancet. Oncology | 2010

von Albain, K. | Barlow, W. | Shak, S. | +20

CommentIn: Lancet Oncol. 2010 Jan;11(1):6-7. - PMID 20005177